The race to develop oral weight loss medications is intensifying as companies like Roche Holdings AG (OTC:RHHBY), Eli Lilly And Co (NYSE:LLY), Novo Nordisk A/S (NYSE:NVO), and Pfizer Inc (NYSE:PFE) strive to create alternatives to injectable drugs. While these pills offer a promising solution in the fight against obesity, experts caution that they may not wholly replace injectable options. Clinical trial data indicate that oral medications could match injectable drugs’ effectiveness and side effects. However, to mitigate side effects, they may require more frequent dosing or produce slightly less weight loss. Related: Craze For Ozempic And Zepbound For Weight Loss Leave Diabetic Patients Without Critical ...